Global Cell Theraputics Market Research Report 2023

Global Cell Theraputics Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Theraputics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Stem Cells
1.2.3 Immunocyte
1.3 Market by Application
1.3.1 Global Cell Theraputics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Allogeneic Cell Therapy
1.3.3 Autologous Cell Therapy
1.3.4 Xenogeneic Cell Therapy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Theraputics Market Perspective (2018-2029)
2.2 Cell Theraputics Growth Trends by Region
2.2.1 Global Cell Theraputics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cell Theraputics Historic Market Size by Region (2018-2023)
2.2.3 Cell Theraputics Forecasted Market Size by Region (2024-2029)
2.3 Cell Theraputics Market Dynamics
2.3.1 Cell Theraputics Industry Trends
2.3.2 Cell Theraputics Market Drivers
2.3.3 Cell Theraputics Market Challenges
2.3.4 Cell Theraputics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Theraputics Players by Revenue
3.1.1 Global Top Cell Theraputics Players by Revenue (2018-2023)
3.1.2 Global Cell Theraputics Revenue Market Share by Players (2018-2023)
3.2 Global Cell Theraputics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Theraputics Revenue
3.4 Global Cell Theraputics Market Concentration Ratio
3.4.1 Global Cell Theraputics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Theraputics Revenue in 2022
3.5 Cell Theraputics Key Players Head office and Area Served
3.6 Key Players Cell Theraputics Product Solution and Service
3.7 Date of Enter into Cell Theraputics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Theraputics Breakdown Data by Type
4.1 Global Cell Theraputics Historic Market Size by Type (2018-2023)
4.2 Global Cell Theraputics Forecasted Market Size by Type (2024-2029)
5 Cell Theraputics Breakdown Data by Application
5.1 Global Cell Theraputics Historic Market Size by Application (2018-2023)
5.2 Global Cell Theraputics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cell Theraputics Market Size (2018-2029)
6.2 North America Cell Theraputics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cell Theraputics Market Size by Country (2018-2023)
6.4 North America Cell Theraputics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Theraputics Market Size (2018-2029)
7.2 Europe Cell Theraputics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cell Theraputics Market Size by Country (2018-2023)
7.4 Europe Cell Theraputics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Theraputics Market Size (2018-2029)
8.2 Asia-Pacific Cell Theraputics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cell Theraputics Market Size by Region (2018-2023)
8.4 Asia-Pacific Cell Theraputics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Theraputics Market Size (2018-2029)
9.2 Latin America Cell Theraputics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cell Theraputics Market Size by Country (2018-2023)
9.4 Latin America Cell Theraputics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Theraputics Market Size (2018-2029)
10.2 Middle East & Africa Cell Theraputics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cell Theraputics Market Size by Country (2018-2023)
10.4 Middle East & Africa Cell Theraputics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb Company (Celgene)
11.1.1 Bristol-Myers Squibb Company (Celgene) Company Detail
11.1.2 Bristol-Myers Squibb Company (Celgene) Business Overview
11.1.3 Bristol-Myers Squibb Company (Celgene) Cell Theraputics Introduction
11.1.4 Bristol-Myers Squibb Company (Celgene) Revenue in Cell Theraputics Business (2018-2023)
11.1.5 Bristol-Myers Squibb Company (Celgene) Recent Development
11.2 Bluebird Bio
11.2.1 Bluebird Bio Company Detail
11.2.2 Bluebird Bio Business Overview
11.2.3 Bluebird Bio Cell Theraputics Introduction
11.2.4 Bluebird Bio Revenue in Cell Theraputics Business (2018-2023)
11.2.5 Bluebird Bio Recent Development
11.3 Crispr Therapeutics
11.3.1 Crispr Therapeutics Company Detail
11.3.2 Crispr Therapeutics Business Overview
11.3.3 Crispr Therapeutics Cell Theraputics Introduction
11.3.4 Crispr Therapeutics Revenue in Cell Theraputics Business (2018-2023)
11.3.5 Crispr Therapeutics Recent Development
11.4 Roche (Spark Therapeutics)
11.4.1 Roche (Spark Therapeutics) Company Detail
11.4.2 Roche (Spark Therapeutics) Business Overview
11.4.3 Roche (Spark Therapeutics) Cell Theraputics Introduction
11.4.4 Roche (Spark Therapeutics) Revenue in Cell Theraputics Business (2018-2023)
11.4.5 Roche (Spark Therapeutics) Recent Development
11.5 PTC Therapeutics
11.5.1 PTC Therapeutics Company Detail
11.5.2 PTC Therapeutics Business Overview
11.5.3 PTC Therapeutics Cell Theraputics Introduction
11.5.4 PTC Therapeutics Revenue in Cell Theraputics Business (2018-2023)
11.5.5 PTC Therapeutics Recent Development
11.6 Moderna Therapeutics
11.6.1 Moderna Therapeutics Company Detail
11.6.2 Moderna Therapeutics Business Overview
11.6.3 Moderna Therapeutics Cell Theraputics Introduction
11.6.4 Moderna Therapeutics Revenue in Cell Theraputics Business (2018-2023)
11.6.5 Moderna Therapeutics Recent Development
11.7 Quanterix
11.7.1 Quanterix Company Detail
11.7.2 Quanterix Business Overview
11.7.3 Quanterix Cell Theraputics Introduction
11.7.4 Quanterix Revenue in Cell Theraputics Business (2018-2023)
11.7.5 Quanterix Recent Development
11.8 Brainstorm Cell Therapeutics Inc.
11.8.1 Brainstorm Cell Therapeutics Inc. Company Detail
11.8.2 Brainstorm Cell Therapeutics Inc. Business Overview
11.8.3 Brainstorm Cell Therapeutics Inc. Cell Theraputics Introduction
11.8.4 Brainstorm Cell Therapeutics Inc. Revenue in Cell Theraputics Business (2018-2023)
11.8.5 Brainstorm Cell Therapeutics Inc. Recent Development
11.9 Lineage Cell Therapeutics
11.9.1 Lineage Cell Therapeutics Company Detail
11.9.2 Lineage Cell Therapeutics Business Overview
11.9.3 Lineage Cell Therapeutics Cell Theraputics Introduction
11.9.4 Lineage Cell Therapeutics Revenue in Cell Theraputics Business (2018-2023)
11.9.5 Lineage Cell Therapeutics Recent Development
11.10 Cti Biopharma
11.10.1 Cti Biopharma Company Detail
11.10.2 Cti Biopharma Business Overview
11.10.3 Cti Biopharma Cell Theraputics Introduction
11.10.4 Cti Biopharma Revenue in Cell Theraputics Business (2018-2023)
11.10.5 Cti Biopharma Recent Development
11.11 Atara Biotherapeutics, Inc
11.11.1 Atara Biotherapeutics, Inc Company Detail
11.11.2 Atara Biotherapeutics, Inc Business Overview
11.11.3 Atara Biotherapeutics, Inc Cell Theraputics Introduction
11.11.4 Atara Biotherapeutics, Inc Revenue in Cell Theraputics Business (2018-2023)
11.11.5 Atara Biotherapeutics, Inc Recent Development
11.12 Adaptimmune
11.12.1 Adaptimmune Company Detail
11.12.2 Adaptimmune Business Overview
11.12.3 Adaptimmune Cell Theraputics Introduction
11.12.4 Adaptimmune Revenue in Cell Theraputics Business (2018-2023)
11.12.5 Adaptimmune Recent Development
11.13 Novartis
11.13.1 Novartis Company Detail
11.13.2 Novartis Business Overview
11.13.3 Novartis Cell Theraputics Introduction
11.13.4 Novartis Revenue in Cell Theraputics Business (2018-2023)
11.13.5 Novartis Recent Development
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Detail
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Cell Theraputics Introduction
11.14.4 Gilead Sciences Revenue in Cell Theraputics Business (2018-2023)
11.14.5 Gilead Sciences Recent Development
11.15 Juno Therapeutics
11.15.1 Juno Therapeutics Company Detail
11.15.2 Juno Therapeutics Business Overview
11.15.3 Juno Therapeutics Cell Theraputics Introduction
11.15.4 Juno Therapeutics Revenue in Cell Theraputics Business (2018-2023)
11.15.5 Juno Therapeutics Recent Development
11.16 Takeda Pharmaceuticals
11.16.1 Takeda Pharmaceuticals Company Detail
11.16.2 Takeda Pharmaceuticals Business Overview
11.16.3 Takeda Pharmaceuticals Cell Theraputics Introduction
11.16.4 Takeda Pharmaceuticals Revenue in Cell Theraputics Business (2018-2023)
11.16.5 Takeda Pharmaceuticals Recent Development
11.17 Celgene
11.17.1 Celgene Company Detail
11.17.2 Celgene Business Overview
11.17.3 Celgene Cell Theraputics Introduction
11.17.4 Celgene Revenue in Cell Theraputics Business (2018-2023)
11.17.5 Celgene Recent Development
11.18 Adaptimmune Therapeutics
11.18.1 Adaptimmune Therapeutics Company Detail
11.18.2 Adaptimmune Therapeutics Business Overview
11.18.3 Adaptimmune Therapeutics Cell Theraputics Introduction
11.18.4 Adaptimmune Therapeutics Revenue in Cell Theraputics Business (2018-2023)
11.18.5 Adaptimmune Therapeutics Recent Development
11.19 CARsgen Therapeutics
11.19.1 CARsgen Therapeutics Company Detail
11.19.2 CARsgen Therapeutics Business Overview
11.19.3 CARsgen Therapeutics Cell Theraputics Introduction
11.19.4 CARsgen Therapeutics Revenue in Cell Theraputics Business (2018-2023)
11.19.5 CARsgen Therapeutics Recent Development
11.20 Precision Biosciences
11.20.1 Precision Biosciences Company Detail
11.20.2 Precision Biosciences Business Overview
11.20.3 Precision Biosciences Cell Theraputics Introduction
11.20.4 Precision Biosciences Revenue in Cell Theraputics Business (2018-2023)
11.20.5 Precision Biosciences Recent Development
11.21 Sangamo Therapeutics
11.21.1 Sangamo Therapeutics Company Detail
11.21.2 Sangamo Therapeutics Business Overview
11.21.3 Sangamo Therapeutics Cell Theraputics Introduction
11.21.4 Sangamo Therapeutics Revenue in Cell Theraputics Business (2018-2023)
11.21.5 Sangamo Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cell Theraputics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Stem Cells
Table 3. Key Players of Immunocyte
Table 4. Global Cell Theraputics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Cell Theraputics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Cell Theraputics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Cell Theraputics Market Share by Region (2018-2023)
Table 8. Global Cell Theraputics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Cell Theraputics Market Share by Region (2024-2029)
Table 10. Cell Theraputics Market Trends
Table 11. Cell Theraputics Market Drivers
Table 12. Cell Theraputics Market Challenges
Table 13. Cell Theraputics Market Restraints
Table 14. Global Cell Theraputics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Cell Theraputics Market Share by Players (2018-2023)
Table 16. Global Top Cell Theraputics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Theraputics as of 2022)
Table 17. Ranking of Global Top Cell Theraputics Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Cell Theraputics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cell Theraputics Product Solution and Service
Table 21. Date of Enter into Cell Theraputics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell Theraputics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Cell Theraputics Revenue Market Share by Type (2018-2023)
Table 25. Global Cell Theraputics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Cell Theraputics Revenue Market Share by Type (2024-2029)
Table 27. Global Cell Theraputics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Cell Theraputics Revenue Market Share by Application (2018-2023)
Table 29. Global Cell Theraputics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Cell Theraputics Revenue Market Share by Application (2024-2029)
Table 31. North America Cell Theraputics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Cell Theraputics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Cell Theraputics Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Cell Theraputics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Cell Theraputics Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Cell Theraputics Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Cell Theraputics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Cell Theraputics Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Cell Theraputics Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Cell Theraputics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Cell Theraputics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Cell Theraputics Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Cell Theraputics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Cell Theraputics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Cell Theraputics Market Size by Country (2024-2029) & (US$ Million)
Table 46. Bristol-Myers Squibb Company (Celgene) Company Detail
Table 47. Bristol-Myers Squibb Company (Celgene) Business Overview
Table 48. Bristol-Myers Squibb Company (Celgene) Cell Theraputics Product
Table 49. Bristol-Myers Squibb Company (Celgene) Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 50. Bristol-Myers Squibb Company (Celgene) Recent Development
Table 51. Bluebird Bio Company Detail
Table 52. Bluebird Bio Business Overview
Table 53. Bluebird Bio Cell Theraputics Product
Table 54. Bluebird Bio Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 55. Bluebird Bio Recent Development
Table 56. Crispr Therapeutics Company Detail
Table 57. Crispr Therapeutics Business Overview
Table 58. Crispr Therapeutics Cell Theraputics Product
Table 59. Crispr Therapeutics Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 60. Crispr Therapeutics Recent Development
Table 61. Roche (Spark Therapeutics) Company Detail
Table 62. Roche (Spark Therapeutics) Business Overview
Table 63. Roche (Spark Therapeutics) Cell Theraputics Product
Table 64. Roche (Spark Therapeutics) Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 65. Roche (Spark Therapeutics) Recent Development
Table 66. PTC Therapeutics Company Detail
Table 67. PTC Therapeutics Business Overview
Table 68. PTC Therapeutics Cell Theraputics Product
Table 69. PTC Therapeutics Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 70. PTC Therapeutics Recent Development
Table 71. Moderna Therapeutics Company Detail
Table 72. Moderna Therapeutics Business Overview
Table 73. Moderna Therapeutics Cell Theraputics Product
Table 74. Moderna Therapeutics Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 75. Moderna Therapeutics Recent Development
Table 76. Quanterix Company Detail
Table 77. Quanterix Business Overview
Table 78. Quanterix Cell Theraputics Product
Table 79. Quanterix Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 80. Quanterix Recent Development
Table 81. Brainstorm Cell Therapeutics Inc. Company Detail
Table 82. Brainstorm Cell Therapeutics Inc. Business Overview
Table 83. Brainstorm Cell Therapeutics Inc. Cell Theraputics Product
Table 84. Brainstorm Cell Therapeutics Inc. Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 85. Brainstorm Cell Therapeutics Inc. Recent Development
Table 86. Lineage Cell Therapeutics Company Detail
Table 87. Lineage Cell Therapeutics Business Overview
Table 88. Lineage Cell Therapeutics Cell Theraputics Product
Table 89. Lineage Cell Therapeutics Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 90. Lineage Cell Therapeutics Recent Development
Table 91. Cti Biopharma Company Detail
Table 92. Cti Biopharma Business Overview
Table 93. Cti Biopharma Cell Theraputics Product
Table 94. Cti Biopharma Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 95. Cti Biopharma Recent Development
Table 96. Atara Biotherapeutics, Inc Company Detail
Table 97. Atara Biotherapeutics, Inc Business Overview
Table 98. Atara Biotherapeutics, Inc Cell Theraputics Product
Table 99. Atara Biotherapeutics, Inc Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 100. Atara Biotherapeutics, Inc Recent Development
Table 101. Adaptimmune Company Detail
Table 102. Adaptimmune Business Overview
Table 103. Adaptimmune Cell Theraputics Product
Table 104. Adaptimmune Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 105. Adaptimmune Recent Development
Table 106. Novartis Company Detail
Table 107. Novartis Business Overview
Table 108. Novartis Cell Theraputics Product
Table 109. Novartis Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 110. Novartis Recent Development
Table 111. Gilead Sciences Company Detail
Table 112. Gilead Sciences Business Overview
Table 113. Gilead Sciences Cell Theraputics Product
Table 114. Gilead Sciences Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 115. Gilead Sciences Recent Development
Table 116. Juno Therapeutics Company Detail
Table 117. Juno Therapeutics Business Overview
Table 118. Juno Therapeutics Cell Theraputics Product
Table 119. Juno Therapeutics Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 120. Juno Therapeutics Recent Development
Table 121. Takeda Pharmaceuticals Company Detail
Table 122. Takeda Pharmaceuticals Business Overview
Table 123. Takeda Pharmaceuticals Cell Theraputics Product
Table 124. Takeda Pharmaceuticals Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 125. Takeda Pharmaceuticals Recent Development
Table 126. Celgene Company Detail
Table 127. Celgene Business Overview
Table 128. Celgene Cell Theraputics Product
Table 129. Celgene Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 130. Celgene Recent Development
Table 131. Adaptimmune Therapeutics Company Detail
Table 132. Adaptimmune Therapeutics Business Overview
Table 133. Adaptimmune Therapeutics Cell Theraputics Product
Table 134. Adaptimmune Therapeutics Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 135. Adaptimmune Therapeutics Recent Development
Table 136. CARsgen Therapeutics Company Detail
Table 137. CARsgen Therapeutics Business Overview
Table 138. CARsgen Therapeutics Cell Theraputics Product
Table 139. CARsgen Therapeutics Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 140. CARsgen Therapeutics Recent Development
Table 141. Precision Biosciences Company Detail
Table 142. Precision Biosciences Business Overview
Table 143. Precision Biosciences Cell Theraputics Product
Table 144. Precision Biosciences Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 145. Precision Biosciences Recent Development
Table 146. Sangamo Therapeutics Company Detail
Table 147. Sangamo Therapeutics Business Overview
Table 148. Sangamo Therapeutics Cell Theraputics Product
Table 149. Sangamo Therapeutics Revenue in Cell Theraputics Business (2018-2023) & (US$ Million)
Table 150. Sangamo Therapeutics Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell Theraputics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cell Theraputics Market Share by Type: 2022 VS 2029
Figure 3. Stem Cells Features
Figure 4. Immunocyte Features
Figure 5. Global Cell Theraputics Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Cell Theraputics Market Share by Application: 2022 VS 2029
Figure 7. Allogeneic Cell Therapy Case Studies
Figure 8. Autologous Cell Therapy Case Studies
Figure 9. Xenogeneic Cell Therapy Case Studies
Figure 10. Cell Theraputics Report Years Considered
Figure 11. Global Cell Theraputics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Cell Theraputics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Cell Theraputics Market Share by Region: 2022 VS 2029
Figure 14. Global Cell Theraputics Market Share by Players in 2022
Figure 15. Global Top Cell Theraputics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Theraputics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Cell Theraputics Revenue in 2022
Figure 17. North America Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Cell Theraputics Market Share by Country (2018-2029)
Figure 19. United States Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Cell Theraputics Market Share by Country (2018-2029)
Figure 23. Germany Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Cell Theraputics Market Share by Region (2018-2029)
Figure 31. China Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Cell Theraputics Market Share by Country (2018-2029)
Figure 39. Mexico Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Cell Theraputics Market Share by Country (2018-2029)
Figure 43. Turkey Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Cell Theraputics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Bristol-Myers Squibb Company (Celgene) Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 46. Bluebird Bio Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 47. Crispr Therapeutics Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 48. Roche (Spark Therapeutics) Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 49. PTC Therapeutics Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 50. Moderna Therapeutics Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 51. Quanterix Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 52. Brainstorm Cell Therapeutics Inc. Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 53. Lineage Cell Therapeutics Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 54. Cti Biopharma Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 55. Atara Biotherapeutics, Inc Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 56. Adaptimmune Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 57. Novartis Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 58. Gilead Sciences Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 59. Juno Therapeutics Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 60. Takeda Pharmaceuticals Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 61. Celgene Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 62. Adaptimmune Therapeutics Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 63. CARsgen Therapeutics Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 64. Precision Biosciences Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 65. Sangamo Therapeutics Revenue Growth Rate in Cell Theraputics Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs